Hypertension Diagnostics' market value is the price at which a share of Hypertension Diagnostics trades on a public exchange. It measures the collective expectations of Hypertension Diagnostics investors about its performance. Hypertension Diagnostics is trading at 1.0E-4 as of the 24th of December 2025. This is a No Change since the beginning of the trading day. The stock's open price was 1.0E-4. With this module, you can estimate the performance of a buy and hold strategy of Hypertension Diagnostics and determine expected loss or profit from investing in Hypertension Diagnostics over a given investment horizon. Check out Hypertension Diagnostics Correlation, Hypertension Diagnostics Volatility and Hypertension Diagnostics Alpha and Beta module to complement your research on Hypertension Diagnostics.
Please note, there is a significant difference between Hypertension Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hypertension Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hypertension Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Hypertension Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hypertension Diagnostics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hypertension Diagnostics.
0.00
11/24/2025
No Change 0.00
0.0
In 30 days
12/24/2025
0.00
If you would invest 0.00 in Hypertension Diagnostics on November 24, 2025 and sell it all today you would earn a total of 0.00 from holding Hypertension Diagnostics or generate 0.0% return on investment in Hypertension Diagnostics over 30 days. Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that... More
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hypertension Diagnostics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hypertension Diagnostics upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hypertension Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hypertension Diagnostics' standard deviation. In reality, there are many statistical measures that can use Hypertension Diagnostics historical prices to predict the future Hypertension Diagnostics' volatility.
We have found sixteen technical indicators for Hypertension Diagnostics, which you can use to evaluate the volatility of the firm. Please check out Hypertension Diagnostics' Market Risk Adjusted Performance of (6.49), standard deviation of 13.85, and Risk Adjusted Performance of 0.0479 to validate if the risk estimate we provide is consistent with the expected return of 0.0%. The company retains a Market Volatility (i.e., Beta) of -0.11, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Hypertension Diagnostics are expected to decrease at a much lower rate. During the bear market, Hypertension Diagnostics is likely to outperform the market. Hypertension Diagnostics right now retains a risk of 0.0%. Please check out Hypertension Diagnostics information ratio and kurtosis , to decide if Hypertension Diagnostics will be following its current trending patterns.
Auto-correlation
0.00
No correlation between past and present
Hypertension Diagnostics has no correlation between past and present. Overlapping area represents the amount of predictability between Hypertension Diagnostics time series from 24th of November 2025 to 9th of December 2025 and 9th of December 2025 to 24th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hypertension Diagnostics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Hypertension Diagnostics price fluctuation can be explain by its past prices.
Correlation Coefficient
0.0
Spearman Rank Test
1.0
Residual Average
0.0
Price Variance
0.0
Hypertension Diagnostics lagged returns against current returns
Autocorrelation, which is Hypertension Diagnostics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Hypertension Diagnostics' pink sheet expected returns. We can calculate the autocorrelation of Hypertension Diagnostics returns to help us make a trade decision. For example, suppose you find that Hypertension Diagnostics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Hypertension Diagnostics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Hypertension Diagnostics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Hypertension Diagnostics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Hypertension Diagnostics pink sheet over time.
Current vs Lagged Prices
Timeline
Hypertension Diagnostics Lagged Returns
When evaluating Hypertension Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Hypertension Diagnostics pink sheet have on its future price. Hypertension Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Hypertension Diagnostics autocorrelation shows the relationship between Hypertension Diagnostics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Hypertension Diagnostics.
Other Information on Investing in Hypertension Pink Sheet
Hypertension Diagnostics financial ratios help investors to determine whether Hypertension Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hypertension with respect to the benefits of owning Hypertension Diagnostics security.